Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the company, through a selling broker, has completed the sale in the open market of the Australis Capital Inc. units on behalf of non-resident shareholders.
Articles
Battelle and Canopy Growth Announce Strategic Collaboration to Advance Cannabis Research
Battelle, the world's largest nonprofit research and development organization, and Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), the world's largest diversified cannabis company, today announced the completion of multiple fully legal cannabis imports from Canada to the United States.
Organigram becomes an official supplier of cannabis in the Province of Saskatchewan
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased announce it has completed the registration process with Saskatchewan Liquor and Gaming Authority (SLGA), making it an official supplier of cannabis for the province.
Curaleaf Earnings Reports Exemplifies Current Marijuana Stock Conundrum
Curaleaf is one of the rising stars of the U.S. marijuana industry, but its latest earnings report should...
Aurora Cannabis to Ship Medical Cannabis to the Czech Republic
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical cannabis products to the Czech Republic, making this the 21st country in which the company operates.
Will December 24 Be The Bottom For Marijuana Stocks?
The sell-off in marijuana stocks has been relentless, but the bottom could be getting close.
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
GW Pharmaceuticals plc (Nasdaq: GWPH), announces positive top-line results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial of EPIDIOLEX® (cannabidiol or CBD) CV in the treatment of seizures associated with Dravet syndrome, a rare and severe form of childhood-onset epilepsy.
Wayland Group Enters the United Kingdom
Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd., an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis.
Grown Rogue to Commence Trading on the Canadian Securities Exchange
Grown Rogue International Inc. (CSE:GRIN) a seed-to-experience cannabis brand announces that the Company's common shares are scheduled to commence trading today on the Canadian Securities Exchange under the ticker symbol "GRIN".
Forecast: Massachusetts Goes Legal, On Pace For $2 BILLION Sales Market
Massachusetts’ marijuana legalization went into full effect this week. Judging by the data, this is going to add significantly...
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse
Under the terms of the agreement, the Company will provide up to C$40 million of secured debt financing with a three-year term and an annual interest rate of 12%, calculated monthly and payable quarterly after receipt of the sales license at PharmHouse’s initial production and processing facility.
Next Ground Floor Opportunity In Legal Marijuana Now Open
The real marijuana growth story is cannabis retail. It's here and it’s just getting started. This is how to pick out the next top marijuana retail stocks before they move
Seruyas Invests $10 Million into Aleafia to Fund Joint Cannabis Retail Venture
The Joint Venture enables multiple income streams throughout the value chain, with Aleafia’s cultivation producing cannabis for processing, extraction, packaging and eventual listing in retail locations and with provincial distributors.
Liberty Health Sciences To Open Five New Dispensaries
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF), a provider of high quality cannabis, announced today that it plans to open two new dispensaries in Miami and Dania Beach by the end of November and three more in Hollywood, Bonita Springs and Orange Park by the end of this December.
